2-Butoxy-6-(hydroxymethyl)oxane-3,4,5-triol | 25320-93-8

• 物质功能分类: 生物化工 - 糖类化合物 - 单糖
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-Butoxy-6-(hydroxymethyl)oxane-3,4,5-triol
• CAS: 25320-93-8
• 化学式: C₁₀H₂₀O₆
• 分子量: 236.26
• InChiKey: BZANQLIRVMZFOS-UHFFFAOYSA-N

物化性质

• 沸点：
  412℃
• 密度：
  1.30
• 闪点：
  203℃

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  99.4
• 氢给体数：
  4
• 氢受体数：
  6

文献信息

• COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
  申请人：Janetka James W.

  公开号：US20120309701A1

  公开（公告）日：2012-12-06

  The present invention encompasses compounds and methods for treating urinary tract infections.

  本发明涵盖了治疗尿路感染的化合物和方法。
• Alkenyl Glycosides and Their Preparation
  申请人：Elevance Renewable Sciences, Inc.

  公开号：US20160200756A1

  公开（公告）日：2016-07-14

  An alkenyl glycoside is prepared by reacting a metathesis-derived unsaturated fatty alcohol containing 10 to 30 carbon atoms with either (1) a reducible monosaccharide or composition hydrolyzable to a reducible monosaccharide, or (2) a hydrocarbyl glycoside produced by reacting an alcohol containing up to 6 carbon atoms with a reducible monosaccharide or composition hydrolyzable to a reducible monosaccharide. Each of these reactions is performed in the presence of an acid catalyst and under conditions sufficient to form the alkenyl glycoside or hydrocarbyl glycoside. The preferred alkenyl glycosides are 9-decen-1-yl glycoside; 9-dodecen-1-yl glycoside; 9-tridecen-1-yl glycoside; 9-pentadecen-1-yl glycoside; 9-octadecen-yl glycoside; or 9-octadecen-1,18-diyl glycoside.

  一种烯基糖苷的制备方法，包括将含有10至30个碳原子的交换反应衍生的不饱和脂肪醇与（1）可还原单糖或可水解成可还原单糖的组合物，或（2）由含有最多6个碳原子的醇与可还原单糖或可水解成可还原单糖的组合物反应而生成的烃基糖苷反应。这些反应均在酸催化剂存在下进行，并在足够形成烯基糖苷或烃基糖苷的条件下进行。首选的烯基糖苷包括9-癸烯-1-基糖苷；9-十二烯-1-基糖苷；9-十三烯-1-基糖苷；9-十五烯-1-基糖苷；9-十八烯-1-基糖苷；或9-十八烯-1,18-二基糖苷。
• Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease
  申请人：Misselwitz Bernd

  公开号：US20070269384A1

  公开（公告）日：2007-11-22

  The invention relates to the use of metal complexes that contain at least one perfluorinated alkyl radical and at least one chelating agent radical and at least one metal ion equivalent of the atomic numbers 21-29, 31-33, 37-39, 42-44, 49 or 57-83, as well as salts thereof for the production of a diagnostic agent for visualizing amyloid-containing plaques.
• US20140275506A1
  申请人：——

  公开号：US20140275506A1

  公开（公告）日：2014-09-18
• METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS
  申请人：VARGEESE Chandra

  公开号：US20190249173A1

  公开（公告）日：2019-08-15

  In some embodiments, the present disclosure pertains to compositions and methods related to delivery of a biologically active agent, wherein the compositions comprise a biologically active agent and a lipid. In various embodiments, the lipid is selected from: lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, alpha-linolenic acid, gamma-linolenic acid, docosa-hexaenoic acid (cis-DHA), turbinaric acid and dilinoleyl. In some embodiments, a composition and method are useful for delivery of a biologically active agent to a particular cell or tissue, e.g., a muscle cell or tissue.